Leonteq Securities AG’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Leonteq Securities AG’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-400	Closed	-$37.2K	–	1366
2021 Q4	$37.2K	Buy	+400	New	+$26.4K	﹤0.01%	957
2021 Q3	–	Sell	-524	Closed	-$35.7K	–	1247
2021 Q2	$35.7K	Hold	524	–	–	﹤0.01%	881
2021 Q1	$36.4K	Sell	524 -67	-11%	-$5.16K	﹤0.01%	818
2020 Q4	$45.4K	Buy	+591	New	+$44.3K	﹤0.01%	803

Leonteq Securities AG's ARNA Position: Q1 2022 in Review

Leonteq Securities AG sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 400 shares — an estimated $37.2K sold.

Leonteq Securities AG first reported a position in ARNA in Q4 2020 and held it in 4 quarters. The position peaked at $45.4K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Leonteq Securities AG reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Leonteq Securities AG sold 400 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $37.2K.
Leonteq Securities AG first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 4 quarters.
Leonteq Securities AG's Arena Pharmaceuticals Inc position peaked at $45.4K in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Leonteq Securities AG's 13F filing for Q1 2022, filed 26 Mar 2026.